Sanofi's Focus On Priority Categories Bears Fruit In Second Quarter
Sanofi says a double-digit gain for its Consumer Healthcare business in Q2 is evidence its new category prioritization strategy is paying off.
You may also be interested in...
Germany's Stada is strengthening its portfolio by taking over distribution of 50 well-established Sanofi Consumer Healthcare brands marketed across Europe.
Following hot on the heels of a 16-strong European OTC sale to Germany’s Stada, Sanofi has divested eight Latin American Consumer Healthcare brands to Brazil's Hypera as part of its ongoing portfolio restructure.
Sanofi is pressing ahead with plans to divest up to 150 consumer health brands by selling a portfolio of 16 products marketed in key European countries to Germany's Stada.